{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:55Z","timestamp":1791348715207,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:00:00Z","timestamp":1311897600000},"content-version":"vor","delay-in-days":270,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305468\/2006-5"],"award-info":[{"award-number":["305468\/2006-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["300665\/2009-1"],"award-info":[{"award-number":["300665\/2009-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.cca.2010.07.028","type":"journal-article","created":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T04:19:41Z","timestamp":1280463581000},"page":"1603-1605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Review on anti-lipoprotein lipase antibodies"],"prefix":"10.1016","volume":"411","author":[{"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joz\u00e9lio Freire","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.07.028_bb0005","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.10624","article-title":"Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus","volume":"46","author":"Reichlin","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.07.028_bb0010","doi-asserted-by":"crossref","first-page":"8034092009","DOI":"10.1155\/2009\/803409","article-title":"Lack of antilipoprotein lipase antibodies in Takayasu's arteritis","volume":"2009","author":"de Carvalho","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.cca.2010.07.028_bb0015","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/art.20630","article-title":"Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?","volume":"50","author":"de Carvalho","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.07.028_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(18)66011-9","article-title":"Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart","volume":"215","author":"Korn","year":"1955","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.07.028_bb0025","series-title":"The metabolic basis of inherited disease","first-page":"1913","article-title":"Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome","author":"Brunzell","year":"1995"},{"key":"10.1016\/j.cca.2010.07.028_bb0030","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.07.028_bb0035","first-page":"319","article-title":"Decreased plasma postheparin lipolytic activity in systemic lupus erythematosus","volume":"31","author":"Kawanishi","year":"1977","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.cca.2010.07.028_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.ATV.4.3.225","article-title":"Plasma triglyceride determines structure-composition in low and high density lipoproteins","volume":"4","author":"Deckelbaum","year":"1984","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.cca.2010.07.028_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.autrev.2007.11.016","article-title":"Systemic lupus erythematosus and \u201clupus dyslipoproteinemia\u201d","volume":"7","author":"de Carvalho","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"49","key":"10.1016\/j.cca.2010.07.028_bb0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1590\/S0482-50042009000600004","article-title":"LAck of anti-lipoprotein l\u00edpase antibodies in Beh\u00e7et\u00b4s disease","volume":"2009","author":"Carvalho","year":"2009","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.cca.2010.07.028_bb0055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780310706","article-title":"Dyslipoproteinemia in pediatric systemic lupus erythematosus","volume":"31","author":"Ilowite","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.07.028_bb0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2010.07.028_bb0065","first-page":"629","article-title":"Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglycride concentrations","volume":"32","author":"Kodera","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2010.07.028_bb0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0961203307081847","article-title":"Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in prymary antiphospholipid syndrome","volume":"16","author":"de Souza","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2010.07.028_bb0075","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.1780361111","article-title":"Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus","volume":"36","author":"Lahita","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.07.028_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0753-3322(03)00083-0","article-title":"Endothelium activation in the anti-phospholipid syndrome","volume":"57","author":"Raschi","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cca.2010.07.028_bb0085","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.07.028_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2010.07.028_bb0095","first-page":"69","article-title":"Effect of interferon on plasma lipoproteins and on the activity of postheparin lipases","volume":"2","author":"Enholm","year":"1982","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.cca.2010.07.028_bb0100","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.07.028_bb0105","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2010.07.028_bb0110","first-page":"791","article-title":"Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy","volume":"82","author":"Pruneta","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2010.07.028_bb0115","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/jc.2005-0205","article-title":"Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia","volume":"90","author":"Pruneta","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2010.07.028_bb0120","unstructured":"de Carvalho, Viana VST, Borba EF, Dias R, Bonf\u00e1 E. Antilipoprotein lipase antibodies in patients with hypertriglyceridemia without associated autoimmune disease. Clin Rev Allergy Immunol (In press)."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:42:36Z","timestamp":1757860956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110004870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":24,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0009898110004870"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.07.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review on anti-lipoprotein lipase antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2010.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}